Europe Surgical Equipment Market Size, Share & Trends Analysis Report By Product (Surgical Sutures And Staplers, Handheld Surgical Devices), By Application, By Country, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 2 Business Days
Europe Point Of Care TB And Drug-resistant TB Testing Market Growth & Trends
The Europe point of care TB and drug-resistant TB testing market size is expected to reach USD 161.05 million by 2030 and is projected to grow at a CAGR of 5.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. This growth is driven by several factors, notably the high prevalence of tuberculosis (TB) and increasing cases of drug-resistant strains. Despite a 25% reduction in TB deaths by 2022, as reported by the Global Tuberculosis Report, progress was significantly impacted by COVID-19. The WHO European Region saw a gain reversal due to pandemic-related disruptions, with TB incidence rates remaining above pre-pandemic levels in 2022. This ongoing challenge underscores the need for practical, rapid diagnostic solutions to manage TB and DR-TB effectively.
Government and regulatory support further drive the market’s expansion. The European Union’s strategic initiatives, such as the Action Plan on Antimicrobial Resistance (AMR) and the WHO’s Regional Platform to End TB in Eastern Europe, emphasize the importance of enhancing diagnostic capabilities and treatment strategies for TB and drug-resistant strains. These initiatives aim to address the setbacks caused by COVID-19 and improve TB outcomes through increased investment in point of care (PoC) technologies. Additionally, the certification of advanced diagnostic tools like QuantiFERON-TB Gold Plus under the EU’s new In Vitro Diagnostic Medical Devices Regulation (IVDR) 2017/746 highlights the regulatory push for higher standards in TB diagnostics, contributing to market growth.
Technological advancements play a crucial role in market expansion. Recent developments in molecular diagnostics, including rapid PCR assays and next-generation sequencing (NGS), have significantly improved the accuracy and speed of TB detection. These innovations enable high-throughput testing and precise identification of drug-resistant strains, addressing the urgent need for timely diagnosis and treatment.
Europe Point Of Care TB And Drug-resistant TB Testing Market Report Highlights
Europe Point Of Care TB And Drug-resistant TB Testing Market Growth & Trends
The Europe point of care TB and drug-resistant TB testing market size is expected to reach USD 161.05 million by 2030 and is projected to grow at a CAGR of 5.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. This growth is driven by several factors, notably the high prevalence of tuberculosis (TB) and increasing cases of drug-resistant strains. Despite a 25% reduction in TB deaths by 2022, as reported by the Global Tuberculosis Report, progress was significantly impacted by COVID-19. The WHO European Region saw a gain reversal due to pandemic-related disruptions, with TB incidence rates remaining above pre-pandemic levels in 2022. This ongoing challenge underscores the need for practical, rapid diagnostic solutions to manage TB and DR-TB effectively.
Government and regulatory support further drive the market’s expansion. The European Union’s strategic initiatives, such as the Action Plan on Antimicrobial Resistance (AMR) and the WHO’s Regional Platform to End TB in Eastern Europe, emphasize the importance of enhancing diagnostic capabilities and treatment strategies for TB and drug-resistant strains. These initiatives aim to address the setbacks caused by COVID-19 and improve TB outcomes through increased investment in point of care (PoC) technologies. Additionally, the certification of advanced diagnostic tools like QuantiFERON-TB Gold Plus under the EU’s new In Vitro Diagnostic Medical Devices Regulation (IVDR) 2017/746 highlights the regulatory push for higher standards in TB diagnostics, contributing to market growth.
Technological advancements play a crucial role in market expansion. Recent developments in molecular diagnostics, including rapid PCR assays and next-generation sequencing (NGS), have significantly improved the accuracy and speed of TB detection. These innovations enable high-throughput testing and precise identification of drug-resistant strains, addressing the urgent need for timely diagnosis and treatment.
Europe Point Of Care TB And Drug-resistant TB Testing Market Report Highlights
- Based on test, the immunoassays segment dominated the market with a substantial share of 34.9% in 2023, due to its rapid results and ease of use.
- In 2023, the clinics and hospitals segment dominated the market with the largest share of 48.1%.
- Clinics and hospitals are primary settings for TB diagnosis and management due to their capacity to offer comprehensive diagnostic and treatment services.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. EUROPE SURGICAL EQUIPMENT MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Europe Surgical Equipment Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. EUROPE SURGICAL EQUIPMENT MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Europe Surgical Equipment Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Surgical Sutures and Staplers
4.3.1. Surgical Sutures and Staplers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Handheld Surgical Devices
4.4.1. Handheld Surgical Devices Market Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4.2. Forceps And Spatulas
4.4.2.1. Forceps And Spatulas Market Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4.3. Retractors
4.4.3.1. Retractors Market Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4.4. Dilators
4.4.4.1. Dilators Market Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4.5. Graspers
4.4.5.1. Graspers Market Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4.6. Auxiliary Equipment
4.4.6.1. Auxiliary Equipment Market Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4.7. Cutter Equipment’s
4.4.7.1. Cutter Equipment’s Market Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4.8. Other
4.4.8.1. Other Equipment’s Market Estimates and Forecasts, 2017 - 2030 (USD Million)
4.5. Electrosurgical Devices
4.5.1. Electrosurgical Devices Market Estimates and Forecasts, 2017 - 2030 (USD Million)
CHAPTER 5. EUROPE SURGICAL EQUIPMENT MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Europe Surgical Equipment Market: Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Neurosurgery
5.3.1. Neurosurgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Plastic and Reconstructive Surgery
5.4.1. Plastic and Reconstructive Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Wound Closure
5.5.1. Wound Closure Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Obstetrics and Gynecology
5.6.1. Obstetrics and Gynecology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Cardiovascular
5.7.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Orthopedic
5.8.1. Orthopedic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. EUROPE SURGICAL EQUIPMENT MARKET: COUNTRY ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Europe Surgical Equipment Market: Country Movement Analysis, 2023 & 2030 (USD Million)
6.3. Germany
6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. France
6.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. Italy
6.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Spain
6.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Norway
6.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Sweden
6.3.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Denmark
6.3.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. B. Braun SE
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Smith & Nephew plc
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Zimmer Biomet
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Stryker
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. Alcon Laboratories, Inc.
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Aspen Surgical Products, Inc.
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. BD
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. Medtronic
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. Johnson & Johnson Services, Inc.
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. EUROPE SURGICAL EQUIPMENT MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Europe Surgical Equipment Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. EUROPE SURGICAL EQUIPMENT MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Europe Surgical Equipment Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Surgical Sutures and Staplers
4.3.1. Surgical Sutures and Staplers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Handheld Surgical Devices
4.4.1. Handheld Surgical Devices Market Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4.2. Forceps And Spatulas
4.4.2.1. Forceps And Spatulas Market Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4.3. Retractors
4.4.3.1. Retractors Market Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4.4. Dilators
4.4.4.1. Dilators Market Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4.5. Graspers
4.4.5.1. Graspers Market Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4.6. Auxiliary Equipment
4.4.6.1. Auxiliary Equipment Market Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4.7. Cutter Equipment’s
4.4.7.1. Cutter Equipment’s Market Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4.8. Other
4.4.8.1. Other Equipment’s Market Estimates and Forecasts, 2017 - 2030 (USD Million)
4.5. Electrosurgical Devices
4.5.1. Electrosurgical Devices Market Estimates and Forecasts, 2017 - 2030 (USD Million)
CHAPTER 5. EUROPE SURGICAL EQUIPMENT MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Europe Surgical Equipment Market: Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Neurosurgery
5.3.1. Neurosurgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Plastic and Reconstructive Surgery
5.4.1. Plastic and Reconstructive Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Wound Closure
5.5.1. Wound Closure Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Obstetrics and Gynecology
5.6.1. Obstetrics and Gynecology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Cardiovascular
5.7.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Orthopedic
5.8.1. Orthopedic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. EUROPE SURGICAL EQUIPMENT MARKET: COUNTRY ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Europe Surgical Equipment Market: Country Movement Analysis, 2023 & 2030 (USD Million)
6.3. Germany
6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. France
6.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. Italy
6.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Spain
6.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Norway
6.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Sweden
6.3.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Denmark
6.3.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. B. Braun SE
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Smith & Nephew plc
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Zimmer Biomet
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Stryker
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. Alcon Laboratories, Inc.
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Aspen Surgical Products, Inc.
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. BD
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. Medtronic
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. Johnson & Johnson Services, Inc.
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
